

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | postsynaptic membrane organization (GO:0001941) | 7.55723089 |
| 2 | myelination (GO:0042552) | 7.22072595 |
| 3 | ensheathment of neurons (GO:0007272) | 7.21781858 |
| 4 | axon ensheathment (GO:0008366) | 7.21781858 |
| 5 | fatty acid elongation (GO:0030497) | 6.82800971 |
| 6 | oligodendrocyte differentiation (GO:0048709) | 5.57278371 |
| 7 | dermatan sulfate biosynthetic process (GO:0030208) | 5.35850045 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.27169740 |
| 9 | astrocyte differentiation (GO:0048708) | 5.23778694 |
| 10 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.21199671 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 5.20414773 |
| 12 | potassium ion import (GO:0010107) | 5.09368065 |
| 13 | dermatan sulfate metabolic process (GO:0030205) | 5.03209838 |
| 14 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.93571705 |
| 15 | sodium ion export (GO:0071436) | 4.90828777 |
| 16 | exploration behavior (GO:0035640) | 4.90104723 |
| 17 | potassium ion homeostasis (GO:0055075) | 4.79906112 |
| 18 | synaptic vesicle maturation (GO:0016188) | 4.78660562 |
| 19 | creatine metabolic process (GO:0006600) | 4.76803099 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.66867946 |
| 21 | chondroitin sulfate catabolic process (GO:0030207) | 4.65045344 |
| 22 | negative regulation of neurotransmitter transport (GO:0051589) | 4.63112000 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.61337151 |
| 24 | presynaptic membrane assembly (GO:0097105) | 4.56261794 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.54174622 |
| 26 | myelin maintenance (GO:0043217) | 4.53486920 |
| 27 | photoreceptor cell differentiation (GO:0046530) | 4.52680507 |
| 28 | eye photoreceptor cell differentiation (GO:0001754) | 4.52680507 |
| 29 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.48272115 |
| 30 | presynaptic membrane organization (GO:0097090) | 4.45605462 |
| 31 | cholesterol biosynthetic process (GO:0006695) | 4.44401990 |
| 32 | asymmetric protein localization (GO:0008105) | 4.38603259 |
| 33 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.33689940 |
| 34 | apical protein localization (GO:0045176) | 4.33519271 |
| 35 | astrocyte development (GO:0014002) | 4.32186773 |
| 36 | synaptic vesicle exocytosis (GO:0016079) | 4.31508280 |
| 37 | neuron cell-cell adhesion (GO:0007158) | 4.31042221 |
| 38 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.30566757 |
| 39 | L-amino acid import (GO:0043092) | 4.18372056 |
| 40 | negative regulation of protein localization to cell surface (GO:2000009) | 4.16499391 |
| 41 | glycerophospholipid catabolic process (GO:0046475) | 4.15442238 |
| 42 | substantia nigra development (GO:0021762) | 4.15252587 |
| 43 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 4.12209781 |
| 44 | glutamate secretion (GO:0014047) | 4.08378671 |
| 45 | vocalization behavior (GO:0071625) | 4.07761194 |
| 46 | nephron tubule formation (GO:0072079) | 4.03719250 |
| 47 | positive regulation of osteoblast proliferation (GO:0033690) | 4.02751095 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.97198691 |
| 49 | adhesion of symbiont to host cell (GO:0044650) | 3.95553469 |
| 50 | virion attachment to host cell (GO:0019062) | 3.95553469 |
| 51 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.91954958 |
| 52 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91078180 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.89894887 |
| 54 | regulation of collateral sprouting (GO:0048670) | 3.88303817 |
| 55 | establishment of mitochondrion localization (GO:0051654) | 3.88244490 |
| 56 | acidic amino acid transport (GO:0015800) | 3.88170910 |
| 57 | sterol biosynthetic process (GO:0016126) | 3.84644554 |
| 58 | peripheral nervous system axon ensheathment (GO:0032292) | 3.81784651 |
| 59 | myelination in peripheral nervous system (GO:0022011) | 3.81784651 |
| 60 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.78970610 |
| 61 | amino acid import (GO:0043090) | 3.75323461 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 3.66574942 |
| 63 | regulation of synapse structural plasticity (GO:0051823) | 3.66262215 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.65399333 |
| 65 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.64721211 |
| 66 | regulation of synaptic vesicle transport (GO:1902803) | 3.64495920 |
| 67 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.62568491 |
| 68 | auditory behavior (GO:0031223) | 3.55915282 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.53966719 |
| 70 | neuromuscular process controlling balance (GO:0050885) | 3.52574829 |
| 71 | mechanosensory behavior (GO:0007638) | 3.52227390 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.52019811 |
| 73 | response to lipoprotein particle (GO:0055094) | 3.52009963 |
| 74 | negative regulation of axonogenesis (GO:0050771) | 3.50376806 |
| 75 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.48860383 |
| 76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47832109 |
| 77 | neurotransmitter secretion (GO:0007269) | 3.47801940 |
| 78 | positive regulation of glial cell differentiation (GO:0045687) | 3.43863098 |
| 79 | positive regulation of gliogenesis (GO:0014015) | 3.41552807 |
| 80 | cerebellar Purkinje cell layer development (GO:0021680) | 3.40904177 |
| 81 | import into cell (GO:0098657) | 3.39162793 |
| 82 | isoprenoid biosynthetic process (GO:0008299) | 3.37330827 |
| 83 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.36015343 |
| 84 | L-glutamate transport (GO:0015813) | 3.35783742 |
| 85 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.35736993 |
| 86 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.31791709 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.30897622 |
| 88 | regulation of neurotransmitter uptake (GO:0051580) | 3.28709104 |
| 89 | response to methylmercury (GO:0051597) | 3.26197304 |
| 90 | glutamate receptor signaling pathway (GO:0007215) | 3.25662152 |
| 91 | Leydig cell differentiation (GO:0033327) | 3.25544910 |
| 92 | protein palmitoylation (GO:0018345) | 3.24662843 |
| 93 | cellular sodium ion homeostasis (GO:0006883) | 3.24302601 |
| 94 | protein localization to synapse (GO:0035418) | 3.23961030 |
| 95 | adult walking behavior (GO:0007628) | 3.23411908 |
| 96 | negative regulation of axon extension (GO:0030517) | 3.23321289 |
| 97 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21037603 |
| 98 | regulation of axon regeneration (GO:0048679) | 3.20792766 |
| 99 | regulation of neuron projection regeneration (GO:0070570) | 3.20792766 |
| 100 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.17784569 |
| 101 | response to redox state (GO:0051775) | 3.16833307 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.16556735 |
| 103 | glial cell differentiation (GO:0010001) | 3.16086590 |
| 104 | regulation of respiratory system process (GO:0044065) | 3.15418143 |
| 105 | cerebellar granule cell differentiation (GO:0021707) | 3.15125860 |
| 106 | regulation of ARF protein signal transduction (GO:0032012) | 3.13241103 |
| 107 | positive regulation of action potential (GO:0045760) | 3.12926719 |
| 108 | response to auditory stimulus (GO:0010996) | 3.12434828 |
| 109 | neuron projection regeneration (GO:0031102) | 3.11002353 |
| 110 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.10569177 |
| 111 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.09459150 |
| 112 | regulation of synaptic plasticity (GO:0048167) | 3.07311369 |
| 113 | enteric nervous system development (GO:0048484) | 3.06334486 |
| 114 | cell communication by electrical coupling (GO:0010644) | 3.05284837 |
| 115 | neuronal ion channel clustering (GO:0045161) | 3.03982729 |
| 116 | cellular response to epinephrine stimulus (GO:0071872) | 3.03089806 |
| 117 | regulation of female receptivity (GO:0045924) | 3.02555866 |
| 118 | adenosine receptor signaling pathway (GO:0001973) | 3.02448609 |
| 119 | regulation of beta-amyloid formation (GO:1902003) | 3.02361605 |
| 120 | peripheral nervous system development (GO:0007422) | 3.01563663 |
| 121 | neurotransmitter transport (GO:0006836) | 3.00168268 |
| 122 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.98627894 |
| 123 | cGMP-mediated signaling (GO:0019934) | 2.97620592 |
| 124 | amyloid precursor protein metabolic process (GO:0042982) | 2.96861272 |
| 125 | positive regulation of membrane potential (GO:0045838) | 2.96593522 |
| 126 | glycosylceramide metabolic process (GO:0006677) | 2.93939165 |
| 127 | gamma-aminobutyric acid transport (GO:0015812) | 2.93506092 |
| 128 | membrane hyperpolarization (GO:0060081) | 2.93282804 |
| 129 | membrane tubulation (GO:0097320) | 2.92985819 |
| 130 | limb bud formation (GO:0060174) | 2.92389192 |
| 131 | adhesion of symbiont to host (GO:0044406) | 2.92220778 |
| 132 | regulation of neurotransmitter levels (GO:0001505) | 2.90832479 |
| 133 | regulation of neurotransmitter transport (GO:0051588) | 2.90005055 |
| 134 | axon development (GO:0061564) | 2.87492518 |
| 135 | glial cell development (GO:0021782) | 2.86606068 |
| 136 | membrane assembly (GO:0071709) | 2.83080208 |
| 137 | negative regulation of JUN kinase activity (GO:0043508) | 2.81353431 |
| 138 | very long-chain fatty acid metabolic process (GO:0000038) | 2.81206049 |
| 139 | neuronal action potential propagation (GO:0019227) | 2.79610788 |
| 140 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.79526050 |
| 141 | magnesium ion transport (GO:0015693) | 2.79186900 |
| 142 | L-serine transport (GO:0015825) | 2.78084707 |
| 143 | neural nucleus development (GO:0048857) | 2.76950281 |
| 144 | nerve growth factor signaling pathway (GO:0038180) | 2.73612213 |
| 145 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.72540442 |
| 146 | regulation of gliogenesis (GO:0014013) | 2.71789573 |
| 147 | neurotransmitter catabolic process (GO:0042135) | 2.70467547 |
| 148 | neuron remodeling (GO:0016322) | 2.66145510 |
| 149 | peptidyl-cysteine modification (GO:0018198) | 2.65656096 |
| 150 | response to epinephrine (GO:0071871) | 2.64011415 |
| 151 | activated T cell proliferation (GO:0050798) | 2.62034956 |
| 152 | dendrite morphogenesis (GO:0048813) | 2.61359862 |
| 153 | positive regulation of neurological system process (GO:0031646) | 2.59877237 |
| 154 | locomotory exploration behavior (GO:0035641) | 2.55525470 |
| 155 | regulation of glial cell differentiation (GO:0045685) | 2.54251018 |
| 156 | cellular response to monoamine stimulus (GO:0071868) | 2.52006375 |
| 157 | cellular response to catecholamine stimulus (GO:0071870) | 2.52006375 |
| 158 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.51943718 |
| 159 | neuron recognition (GO:0008038) | 2.51407900 |
| 160 | Sertoli cell development (GO:0060009) | 2.50864387 |
| 161 | dendritic spine morphogenesis (GO:0060997) | 2.50670985 |
| 162 | neurotransmitter uptake (GO:0001504) | 2.49453210 |
| 163 | lateral sprouting from an epithelium (GO:0060601) | 2.48895170 |
| 164 | thioester biosynthetic process (GO:0035384) | 2.45527826 |
| 165 | acyl-CoA biosynthetic process (GO:0071616) | 2.45527826 |
| 166 | nucleotide transmembrane transport (GO:1901679) | 2.41285689 |
| 167 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.38476005 |
| 168 | ear development (GO:0043583) | 2.37872100 |
| 169 | central nervous system myelination (GO:0022010) | 10.4833541 |
| 170 | axon ensheathment in central nervous system (GO:0032291) | 10.4833541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.59508455 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00446385 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.81307984 |
| 4 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.67959412 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.62648853 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59459461 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.56871525 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46108462 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.39252258 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33270613 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33270613 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.32179788 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24486836 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23397363 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23316457 |
| 16 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14883743 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12080612 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09199715 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08213793 |
| 20 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07496667 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05582215 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04522794 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03981014 |
| 24 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.01899027 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.95211749 |
| 26 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.91391842 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89955269 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87959351 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86751341 |
| 30 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.74809022 |
| 31 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.69326506 |
| 32 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.67272432 |
| 33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.64984874 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.64393264 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63961890 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62943853 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.62916126 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.61450226 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58645951 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56267555 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55521966 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55126388 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.54383111 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50733657 |
| 45 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.50040757 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48828495 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47328849 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45258544 |
| 49 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42859740 |
| 50 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.42755651 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42687342 |
| 52 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40343943 |
| 53 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.38886203 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36359178 |
| 55 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.34598500 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33772712 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33290263 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33042164 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29178297 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24288238 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23480693 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22568561 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22097005 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21930613 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21164233 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20968301 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19543238 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18784911 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18723154 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16934593 |
| 71 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.13729473 |
| 72 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13159339 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12731597 |
| 74 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12137908 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11905020 |
| 76 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11497439 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10675401 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06656431 |
| 79 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.03756335 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03417102 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02946384 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02553576 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02240524 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01877049 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00596281 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99787211 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99663395 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99663395 |
| 89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99056891 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99013338 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98986283 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98441820 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97458714 |
| 94 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.97192036 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96381820 |
| 96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.95856019 |
| 97 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95663731 |
| 98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95243827 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95163214 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94364442 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94008719 |
| 102 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93972135 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 0.93940348 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93783862 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93782910 |
| 106 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.93450258 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92838338 |
| 108 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92750712 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92718144 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92346427 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92327682 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92264797 |
| 113 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92234850 |
| 114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92033110 |
| 115 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91849969 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91451519 |
| 117 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91113298 |
| 118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90899896 |
| 119 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90556812 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90187407 |
| 121 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88645973 |
| 122 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.88521423 |
| 123 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88125109 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88041270 |
| 125 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87954932 |
| 126 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87857542 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87317868 |
| 128 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87105773 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86738233 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86557561 |
| 131 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86443366 |
| 132 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85238558 |
| 133 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84739301 |
| 134 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84315457 |
| 135 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82722762 |
| 136 | TBL1_22424771_ChIP-Seq_293T_Human | 0.82656030 |
| 137 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81694906 |
| 138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81147945 |
| 139 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80972545 |
| 140 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.80576825 |
| 141 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80571660 |
| 142 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.80135242 |
| 143 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.72469329 |
| 144 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.70765042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.42451304 |
| 2 | MP0003880_abnormal_central_pattern | 4.25955238 |
| 3 | MP0004270_analgesia | 3.43558391 |
| 4 | MP0003690_abnormal_glial_cell | 3.20276734 |
| 5 | MP0004885_abnormal_endolymph | 3.05058434 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.95093591 |
| 7 | MP0003950_abnormal_plasma_membrane | 2.86190991 |
| 8 | MP0003329_amyloid_beta_deposits | 2.64969489 |
| 9 | MP0003136_yellow_coat_color | 2.64323149 |
| 10 | MP0000778_abnormal_nervous_system | 2.63923550 |
| 11 | MP0005171_absent_coat_pigmentation | 2.62918905 |
| 12 | * MP0003634_abnormal_glial_cell | 2.61906448 |
| 13 | MP0001486_abnormal_startle_reflex | 2.59130081 |
| 14 | MP0004742_abnormal_vestibular_system | 2.56995187 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.53069141 |
| 16 | MP0002272_abnormal_nervous_system | 2.50265635 |
| 17 | MP0004142_abnormal_muscle_tone | 2.49788001 |
| 18 | MP0002064_seizures | 2.46671834 |
| 19 | MP0001529_abnormal_vocalization | 2.36164685 |
| 20 | MP0001485_abnormal_pinna_reflex | 2.32297568 |
| 21 | MP0001905_abnormal_dopamine_level | 2.25609692 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.24551363 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.14158784 |
| 24 | MP0009745_abnormal_behavioral_response | 2.02744504 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.99133844 |
| 26 | MP0003632_abnormal_nervous_system | 1.87057676 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.83526931 |
| 28 | MP0005409_darkened_coat_color | 1.79750482 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.77844680 |
| 30 | MP0009046_muscle_twitch | 1.75932760 |
| 31 | MP0002229_neurodegeneration | 1.75457445 |
| 32 | MP0003879_abnormal_hair_cell | 1.70611145 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.67505020 |
| 34 | MP0000462_abnormal_digestive_system | 1.66416453 |
| 35 | * MP0000955_abnormal_spinal_cord | 1.61848005 |
| 36 | MP0003075_altered_response_to | 1.56679503 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.54320051 |
| 38 | MP0000383_abnormal_hair_follicle | 1.53104991 |
| 39 | MP0005451_abnormal_body_composition | 1.51626683 |
| 40 | * MP0002882_abnormal_neuron_morphology | 1.50303687 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.49937673 |
| 42 | MP0005410_abnormal_fertilization | 1.48282982 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.44078444 |
| 44 | MP0004134_abnormal_chest_morphology | 1.43665559 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.43004387 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.42202391 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.38708917 |
| 48 | MP0004381_abnormal_hair_follicle | 1.36476292 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.36064058 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.30794956 |
| 51 | MP0008569_lethality_at_weaning | 1.30580869 |
| 52 | MP0001963_abnormal_hearing_physiology | 1.26649269 |
| 53 | MP0000604_amyloidosis | 1.24630970 |
| 54 | MP0003631_nervous_system_phenotype | 1.23861549 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.23039091 |
| 56 | MP0003787_abnormal_imprinting | 1.22391276 |
| 57 | MP0002752_abnormal_somatic_nervous | 1.21509355 |
| 58 | MP0001970_abnormal_pain_threshold | 1.17045823 |
| 59 | MP0000467_abnormal_esophagus_morphology | 1.15587278 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.15451012 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.15085265 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.12580470 |
| 63 | MP0004924_abnormal_behavior | 1.12580470 |
| 64 | MP0001968_abnormal_touch/_nociception | 1.11295837 |
| 65 | MP0002736_abnormal_nociception_after | 1.09074118 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.09060455 |
| 67 | MP0003938_abnormal_ear_development | 1.08294821 |
| 68 | * MP0002152_abnormal_brain_morphology | 1.08039245 |
| 69 | MP0004130_abnormal_muscle_cell | 1.03825885 |
| 70 | MP0000747_muscle_weakness | 1.03748731 |
| 71 | MP0000647_abnormal_sebaceous_gland | 1.00233063 |
| 72 | MP0001661_extended_life_span | 0.99921329 |
| 73 | MP0004043_abnormal_pH_regulation | 0.98612037 |
| 74 | MP0003633_abnormal_nervous_system | 0.98133407 |
| 75 | MP0001346_abnormal_lacrimal_gland | 0.97994633 |
| 76 | MP0006276_abnormal_autonomic_nervous | 0.95675306 |
| 77 | MP0003937_abnormal_limbs/digits/tail_de | 0.94246957 |
| 78 | MP0000026_abnormal_inner_ear | 0.92894932 |
| 79 | MP0004858_abnormal_nervous_system | 0.91899961 |
| 80 | MP0005195_abnormal_posterior_eye | 0.91729838 |
| 81 | MP0002557_abnormal_social/conspecific_i | 0.89686845 |
| 82 | MP0002184_abnormal_innervation | 0.87717528 |
| 83 | MP0000566_synostosis | 0.87457655 |
| 84 | MP0005166_decreased_susceptibility_to | 0.86590055 |
| 85 | MP0000579_abnormal_nail_morphology | 0.85852109 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.85789170 |
| 87 | MP0000762_abnormal_tongue_morphology | 0.85107167 |
| 88 | MP0001177_atelectasis | 0.84569902 |
| 89 | MP0006072_abnormal_retinal_apoptosis | 0.84162788 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 0.81419294 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 0.80438027 |
| 92 | MP0004811_abnormal_neuron_physiology | 0.79779731 |
| 93 | MP0002822_catalepsy | 0.78794517 |
| 94 | MP0004147_increased_porphyrin_level | 0.76273142 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.76239495 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.75668917 |
| 97 | MP0008874_decreased_physiological_sensi | 0.75624135 |
| 98 | MP0002069_abnormal_eating/drinking_beha | 0.73742802 |
| 99 | MP0005253_abnormal_eye_physiology | 0.73039169 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.72848074 |
| 101 | * MP0003861_abnormal_nervous_system | 0.72255339 |
| 102 | MP0001851_eye_inflammation | 0.71787305 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.71684950 |
| 104 | MP0009278_abnormal_bone_marrow | 0.71631457 |
| 105 | MP0002735_abnormal_chemical_nociception | 0.71253482 |
| 106 | MP0008260_abnormal_autophagy | 0.70830436 |
| 107 | MP0005646_abnormal_pituitary_gland | 0.70205196 |
| 108 | MP0002090_abnormal_vision | 0.70131374 |
| 109 | MP0001943_abnormal_respiration | 0.69680192 |
| 110 | MP0001984_abnormal_olfaction | 0.65307629 |
| 111 | MP0005535_abnormal_body_temperature | 0.65096021 |
| 112 | MP0009780_abnormal_chondrocyte_physiolo | 0.63287653 |
| 113 | MP0001340_abnormal_eyelid_morphology | 0.63223773 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.63094250 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.63033927 |
| 116 | MP0005408_hypopigmentation | 0.62828817 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.61576644 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.58371085 |
| 119 | MP0002133_abnormal_respiratory_system | 0.57987230 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.55355747 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.53600398 |
| 122 | MP0005388_respiratory_system_phenotype | 0.52570094 |
| 123 | MP0001958_emphysema | 0.50157906 |
| 124 | MP0001731_abnormal_postnatal_growth | 0.48734168 |
| 125 | MP0010769_abnormal_survival | 0.48704536 |
| 126 | MP0003283_abnormal_digestive_organ | 0.47930525 |
| 127 | MP0003956_abnormal_body_size | 0.47314628 |
| 128 | MP0003123_paternal_imprinting | 0.46568722 |
| 129 | MP0010770_preweaning_lethality | 0.45053114 |
| 130 | MP0002082_postnatal_lethality | 0.45053114 |
| 131 | MP0009379_abnormal_foot_pigmentation | 0.44914505 |
| 132 | MP0010768_mortality/aging | 0.44895306 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.44220606 |
| 134 | MP0003137_abnormal_impulse_conducting | 0.43639104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.24880148 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.24880148 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.16576240 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 5.24293168 |
| 5 | Peripheral hypomyelination (HP:0007182) | 5.09219672 |
| 6 | Abnormality of binocular vision (HP:0011514) | 5.05311735 |
| 7 | Diplopia (HP:0000651) | 5.05311735 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.79821075 |
| 9 | Parakeratosis (HP:0001036) | 4.57186255 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.48885412 |
| 11 | Obstructive sleep apnea (HP:0002870) | 4.15950930 |
| 12 | Cerebral hypomyelination (HP:0006808) | 3.98839806 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.87905171 |
| 14 | Hemiplegia (HP:0002301) | 3.78249520 |
| 15 | Spastic gait (HP:0002064) | 3.69122799 |
| 16 | Focal seizures (HP:0007359) | 3.67480056 |
| 17 | Abnormal auditory evoked potentials (HP:0006958) | 3.62918501 |
| 18 | Alacrima (HP:0000522) | 3.55501564 |
| 19 | Abnormal eating behavior (HP:0100738) | 3.54057719 |
| 20 | Onion bulb formation (HP:0003383) | 3.53037237 |
| 21 | Intention tremor (HP:0002080) | 3.44528121 |
| 22 | Akinesia (HP:0002304) | 3.41043182 |
| 23 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.38904591 |
| 24 | Oligodactyly (hands) (HP:0001180) | 3.35995101 |
| 25 | Abnormality of the pulmonary veins (HP:0011718) | 3.29069622 |
| 26 | Myokymia (HP:0002411) | 3.23733420 |
| 27 | Dysmetria (HP:0001310) | 3.16960028 |
| 28 | Retinal dysplasia (HP:0007973) | 3.14278374 |
| 29 | Febrile seizures (HP:0002373) | 3.06442918 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 3.06399381 |
| 31 | Megalencephaly (HP:0001355) | 3.04699378 |
| 32 | Hemiparesis (HP:0001269) | 3.03660065 |
| 33 | Termporal pattern (HP:0011008) | 3.02707250 |
| 34 | Insidious onset (HP:0003587) | 3.02707250 |
| 35 | Mutism (HP:0002300) | 3.01342292 |
| 36 | Hypoplastic pelvis (HP:0008839) | 3.00392542 |
| 37 | Ankle clonus (HP:0011448) | 2.96476973 |
| 38 | Spastic paraparesis (HP:0002313) | 2.96083687 |
| 39 | Absent septum pellucidum (HP:0001331) | 2.95626689 |
| 40 | Insomnia (HP:0100785) | 2.86020227 |
| 41 | Morphological abnormality of the inner ear (HP:0011390) | 2.85662768 |
| 42 | Split foot (HP:0001839) | 2.83178766 |
| 43 | Decreased lacrimation (HP:0000633) | 2.79697921 |
| 44 | Abnormality of cochlea (HP:0000375) | 2.78064262 |
| 45 | Premature skin wrinkling (HP:0100678) | 2.75856561 |
| 46 | Thickened helices (HP:0000391) | 2.75808024 |
| 47 | Leukodystrophy (HP:0002415) | 2.73117327 |
| 48 | Limb dystonia (HP:0002451) | 2.67476393 |
| 49 | Slow saccadic eye movements (HP:0000514) | 2.65885581 |
| 50 | Postural instability (HP:0002172) | 2.64755294 |
| 51 | Truncal ataxia (HP:0002078) | 2.60121828 |
| 52 | Anteriorly placed anus (HP:0001545) | 2.58387608 |
| 53 | Sleep apnea (HP:0010535) | 2.55967883 |
| 54 | Coronal craniosynostosis (HP:0004440) | 2.55614396 |
| 55 | Humeroradial synostosis (HP:0003041) | 2.55154593 |
| 56 | Synostosis involving the elbow (HP:0003938) | 2.55154593 |
| 57 | Septo-optic dysplasia (HP:0100842) | 2.54920280 |
| 58 | Apathy (HP:0000741) | 2.54222822 |
| 59 | Neuronal loss in central nervous system (HP:0002529) | 2.52901989 |
| 60 | Scanning speech (HP:0002168) | 2.51736544 |
| 61 | Increased circulating renin level (HP:0000848) | 2.51506215 |
| 62 | Papilledema (HP:0001085) | 2.51345940 |
| 63 | Abnormality of the septum pellucidum (HP:0007375) | 2.47423493 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.46294401 |
| 65 | Increased serum pyruvate (HP:0003542) | 2.46294401 |
| 66 | Rigidity (HP:0002063) | 2.45999180 |
| 67 | Clumsiness (HP:0002312) | 2.45013778 |
| 68 | Hypoplasia of the iris (HP:0007676) | 2.42436747 |
| 69 | CNS hypomyelination (HP:0003429) | 2.41795279 |
| 70 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.41073123 |
| 71 | Pheochromocytoma (HP:0002666) | 2.40537143 |
| 72 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.36597147 |
| 73 | Aplasia of the phalanges of the hand (HP:0009802) | 2.36597147 |
| 74 | Aplasia involving bones of the extremities (HP:0009825) | 2.36597147 |
| 75 | Truncus arteriosus (HP:0001660) | 2.36561939 |
| 76 | Torticollis (HP:0000473) | 2.32809848 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31015487 |
| 78 | Partial agenesis of the corpus callosum (HP:0001338) | 2.30672952 |
| 79 | Diminished motivation (HP:0000745) | 2.29733566 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.28404981 |
| 81 | Depression (HP:0000716) | 2.27416736 |
| 82 | Relative macrocephaly (HP:0004482) | 2.23018421 |
| 83 | Abnormality of the diencephalon (HP:0010662) | 2.22083759 |
| 84 | Anxiety (HP:0000739) | 2.20879398 |
| 85 | Oligodactyly (HP:0012165) | 2.20819965 |
| 86 | Abnormality of the periventricular white matter (HP:0002518) | 2.20815189 |
| 87 | Lower limb muscle weakness (HP:0007340) | 2.19254904 |
| 88 | Rapidly progressive (HP:0003678) | 2.17794295 |
| 89 | Muscle fiber splitting (HP:0003555) | 2.17661919 |
| 90 | Absence seizures (HP:0002121) | 2.17631940 |
| 91 | Abnormality of the 4th metacarpal (HP:0010012) | 2.17339455 |
| 92 | Tetraplegia (HP:0002445) | 2.16604426 |
| 93 | Autoamputation (HP:0001218) | 2.13808485 |
| 94 | Ankyloglossia (HP:0010296) | 2.12869055 |
| 95 | White forelock (HP:0002211) | 2.12868119 |
| 96 | Bradykinesia (HP:0002067) | 2.11644134 |
| 97 | Cerebral hemorrhage (HP:0001342) | 2.11229454 |
| 98 | Overriding aorta (HP:0002623) | 2.10161810 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 2.08827792 |
| 100 | Cupped ear (HP:0000378) | 2.06156650 |
| 101 | Paraparesis (HP:0002385) | 2.05926077 |
| 102 | Patchy hypopigmentation of hair (HP:0011365) | 2.04760223 |
| 103 | Delusions (HP:0000746) | 2.04397357 |
| 104 | Esophageal atresia (HP:0002032) | 2.04328438 |
| 105 | Progressive cerebellar ataxia (HP:0002073) | 2.02116031 |
| 106 | Visual hallucinations (HP:0002367) | 2.01481257 |
| 107 | Action tremor (HP:0002345) | 2.01147952 |
| 108 | Spastic tetraparesis (HP:0001285) | 2.00917783 |
| 109 | Infantile muscular hypotonia (HP:0008947) | 2.00767207 |
| 110 | Hyporeflexia of lower limbs (HP:0002600) | 2.00433636 |
| 111 | Atonic seizures (HP:0010819) | 1.98931405 |
| 112 | Hypomagnesemia (HP:0002917) | 1.98710108 |
| 113 | Stridor (HP:0010307) | 1.98656797 |
| 114 | Metabolic alkalosis (HP:0200114) | 1.96871294 |
| 115 | Stereotypic behavior (HP:0000733) | 1.96681577 |
| 116 | Hyperacusis (HP:0010780) | 1.96587040 |
| 117 | Hyperparathyroidism (HP:0000843) | 1.96492133 |
| 118 | Chin dimple (HP:0010751) | 1.95824044 |
| 119 | Clonus (HP:0002169) | 1.93621036 |
| 120 | Polyphagia (HP:0002591) | 1.93609124 |
| 121 | Dialeptic seizures (HP:0011146) | 1.93404768 |
| 122 | Urethral obstruction (HP:0000796) | 1.92278828 |
| 123 | Anomalous pulmonary venous return (HP:0010772) | 1.92207103 |
| 124 | Urinary incontinence (HP:0000020) | 1.90831624 |
| 125 | Bowel incontinence (HP:0002607) | 1.90631493 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90269635 |
| 127 | Elfin facies (HP:0004428) | 1.89834100 |
| 128 | Adrenal hypoplasia (HP:0000835) | 1.89243992 |
| 129 | Axonal loss (HP:0003447) | 1.89218964 |
| 130 | Urinary urgency (HP:0000012) | 1.87482553 |
| 131 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.87160208 |
| 132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85373168 |
| 133 | Turricephaly (HP:0000262) | 1.84869792 |
| 134 | Partial duplication of thumb phalanx (HP:0009944) | 1.84357971 |
| 135 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.83402350 |
| 136 | Foot dorsiflexor weakness (HP:0009027) | 1.82734534 |
| 137 | Type II lissencephaly (HP:0007260) | 1.82596196 |
| 138 | Annular pancreas (HP:0001734) | 1.82078821 |
| 139 | Diminished movement (HP:0002374) | 1.81528826 |
| 140 | Hypokalemic alkalosis (HP:0001949) | 1.80571590 |
| 141 | Decreased motor nerve conduction velocity (HP:0003431) | 1.79457766 |
| 142 | Abnormal large intestine physiology (HP:0012700) | 1.79160937 |
| 143 | Choreoathetosis (HP:0001266) | 1.78557199 |
| 144 | Abnormality of the foot musculature (HP:0001436) | 1.78288504 |
| 145 | Barrel-shaped chest (HP:0001552) | 1.76630646 |
| 146 | Hyperventilation (HP:0002883) | 1.76179261 |
| 147 | Distal sensory impairment (HP:0002936) | 1.75907096 |
| 148 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.75881156 |
| 149 | Hammertoe (HP:0001765) | 1.75151870 |
| 150 | Methylmalonic acidemia (HP:0002912) | 1.74704702 |
| 151 | Generalized myoclonic seizures (HP:0002123) | 1.73969831 |
| 152 | Focal dystonia (HP:0004373) | 1.73846100 |
| 153 | Poor speech (HP:0002465) | 1.73822678 |
| 154 | Dementia (HP:0000726) | 1.73500122 |
| 155 | Epileptic encephalopathy (HP:0200134) | 1.71724695 |
| 156 | Memory impairment (HP:0002354) | 1.71304149 |
| 157 | Steppage gait (HP:0003376) | 1.67050921 |
| 158 | Dysdiadochokinesis (HP:0002075) | 1.65929348 |
| 159 | Focal motor seizures (HP:0011153) | 1.65849239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.71545621 |
| 2 | OXSR1 | 4.32449567 |
| 3 | EPHB1 | 3.01253600 |
| 4 | TNIK | 2.85632287 |
| 5 | TNK2 | 2.85182105 |
| 6 | CDK19 | 2.82388829 |
| 7 | BCR | 2.64256964 |
| 8 | PKN1 | 2.36003204 |
| 9 | ICK | 2.27656930 |
| 10 | LIMK1 | 2.17794590 |
| 11 | WNK4 | 2.17493828 |
| 12 | MET | 2.14188258 |
| 13 | PBK | 2.12929670 |
| 14 | NEK6 | 2.09643960 |
| 15 | CSNK1G3 | 1.98884709 |
| 16 | TYRO3 | 1.92268496 |
| 17 | FGFR2 | 1.90366975 |
| 18 | CSNK1A1L | 1.88950718 |
| 19 | UHMK1 | 1.85827380 |
| 20 | CASK | 1.83656221 |
| 21 | DAPK2 | 1.83373651 |
| 22 | PAK6 | 1.82969546 |
| 23 | NTRK1 | 1.82814843 |
| 24 | MAPKAPK5 | 1.79639604 |
| 25 | WNK1 | 1.74431753 |
| 26 | PRPF4B | 1.65189232 |
| 27 | ROCK2 | 1.64851600 |
| 28 | TESK2 | 1.59783074 |
| 29 | EPHA4 | 1.59501972 |
| 30 | PNCK | 1.58398949 |
| 31 | CAMKK1 | 1.56225837 |
| 32 | CSNK1G2 | 1.55793067 |
| 33 | CSNK1G1 | 1.54785647 |
| 34 | MARK1 | 1.49374012 |
| 35 | FGR | 1.48298415 |
| 36 | SGK2 | 1.45529980 |
| 37 | CAMK2B | 1.36863195 |
| 38 | RIPK1 | 1.35446396 |
| 39 | RIPK4 | 1.31208528 |
| 40 | CLK1 | 1.17098048 |
| 41 | CAMK2D | 1.15047654 |
| 42 | SIK2 | 1.14152811 |
| 43 | CDK14 | 1.10825918 |
| 44 | SGK3 | 1.10636535 |
| 45 | ERBB4 | 1.09299615 |
| 46 | PAK3 | 1.08389769 |
| 47 | MAPK12 | 1.01018962 |
| 48 | PINK1 | 0.99128096 |
| 49 | CDK15 | 0.98839938 |
| 50 | NTRK2 | 0.96069815 |
| 51 | CDK5 | 0.95295998 |
| 52 | SGK1 | 0.94287057 |
| 53 | PHKG1 | 0.93994023 |
| 54 | PHKG2 | 0.93994023 |
| 55 | CDK18 | 0.92671741 |
| 56 | IRAK2 | 0.92008642 |
| 57 | PDGFRA | 0.91701337 |
| 58 | CAMK2G | 0.91504337 |
| 59 | CDK11A | 0.90919035 |
| 60 | PLK2 | 0.87441138 |
| 61 | SGK494 | 0.87393242 |
| 62 | SGK223 | 0.87393242 |
| 63 | ALK | 0.82694741 |
| 64 | PDGFRB | 0.81916029 |
| 65 | DYRK2 | 0.79892058 |
| 66 | PRKCG | 0.79864175 |
| 67 | PRKCQ | 0.77985482 |
| 68 | CAMK2A | 0.76769710 |
| 69 | CAMK1 | 0.75619407 |
| 70 | KSR2 | 0.75456650 |
| 71 | ARAF | 0.75171554 |
| 72 | MUSK | 0.73953342 |
| 73 | FES | 0.73176807 |
| 74 | MAPK15 | 0.70514941 |
| 75 | MARK2 | 0.69883828 |
| 76 | LMTK2 | 0.69499193 |
| 77 | RAF1 | 0.68665235 |
| 78 | MST4 | 0.67078211 |
| 79 | STK38 | 0.65973665 |
| 80 | PRKD1 | 0.64605142 |
| 81 | FYN | 0.64474549 |
| 82 | IRAK1 | 0.63814942 |
| 83 | BMX | 0.63578936 |
| 84 | PRKCZ | 0.63133445 |
| 85 | GRK5 | 0.61733681 |
| 86 | CSNK1D | 0.56789611 |
| 87 | PRKCE | 0.56492332 |
| 88 | PDPK1 | 0.55656567 |
| 89 | PRKCH | 0.53225153 |
| 90 | STK11 | 0.52582894 |
| 91 | MAPK13 | 0.51096325 |
| 92 | CAMK4 | 0.50713965 |
| 93 | JAK2 | 0.50308915 |
| 94 | PIK3CA | 0.50176750 |
| 95 | MAP2K4 | 0.48469568 |
| 96 | PRKD3 | 0.48080151 |
| 97 | NTRK3 | 0.48037210 |
| 98 | PDK1 | 0.47552556 |
| 99 | CAMK1G | 0.44893646 |
| 100 | MAP3K13 | 0.43892106 |
| 101 | ROCK1 | 0.43292136 |
| 102 | RPS6KA3 | 0.43276198 |
| 103 | DMPK | 0.42537806 |
| 104 | PRKG1 | 0.41243463 |
| 105 | MAP3K9 | 0.40171747 |
| 106 | GSK3A | 0.39100064 |
| 107 | DYRK1A | 0.38611508 |
| 108 | DDR2 | 0.37867521 |
| 109 | MAP3K1 | 0.37390226 |
| 110 | CSNK1A1 | 0.37248823 |
| 111 | JAK1 | 0.36783528 |
| 112 | PAK1 | 0.35889025 |
| 113 | MOS | 0.34335930 |
| 114 | CDK3 | 0.34333615 |
| 115 | PRKACB | 0.34284928 |
| 116 | RPS6KB1 | 0.33591768 |
| 117 | BMPR2 | 0.32202772 |
| 118 | BMPR1B | 0.31644337 |
| 119 | MAP2K1 | 0.31186732 |
| 120 | KSR1 | 0.30573187 |
| 121 | RPS6KA5 | 0.30206114 |
| 122 | TRPM7 | 0.29587884 |
| 123 | MAP3K11 | 0.29535441 |
| 124 | MAPK4 | 0.28616183 |
| 125 | MAPK10 | 0.28358605 |
| 126 | INSR | 0.27386560 |
| 127 | PRKG2 | 0.26690203 |
| 128 | ERBB2 | 0.26241135 |
| 129 | MKNK1 | 0.26202762 |
| 130 | CSK | 0.25182327 |
| 131 | MINK1 | 0.24856697 |
| 132 | MAPK7 | 0.24142855 |
| 133 | MAP3K2 | 0.23307830 |
| 134 | SRC | 0.23048312 |
| 135 | RET | 0.21907636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.04308268 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.56595272 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.94361061 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.66782951 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.76646465 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.73028772 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.68923465 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.60862368 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.39700485 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 2.15633065 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.03604734 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87292415 |
| 13 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.69261173 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67700967 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.62073543 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60609055 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.55554490 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.54736148 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53761917 |
| 20 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.50477787 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50418419 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40749638 |
| 23 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.37077363 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.33122874 |
| 25 | Glioma_Homo sapiens_hsa05214 | 1.32196692 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.29323936 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28495157 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.20649230 |
| 29 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18548751 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17175042 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.16686066 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15703055 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14215096 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11490697 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.11228941 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.10866850 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10602865 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09697800 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.07706870 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.05483789 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05454334 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05299189 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03447985 |
| 44 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.02352687 |
| 45 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01579320 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00409195 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99187985 |
| 48 | Nicotine addiction_Homo sapiens_hsa05033 | 0.97090638 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 0.95310971 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94086633 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 0.93247155 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92820004 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92312864 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.91606438 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91603837 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91037465 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90839274 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89596745 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87567277 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87559906 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86882819 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83335730 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82689963 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81837135 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81126687 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79811909 |
| 67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79451891 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.79068295 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77571584 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77159149 |
| 71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75950328 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75912589 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75490692 |
| 74 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.75081955 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.74962377 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74531145 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73470768 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71393219 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67756066 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66585953 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65519943 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61423153 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59809839 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59399652 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59373288 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59034650 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58930015 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58639702 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58279649 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57764086 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57391505 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.56563250 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54826799 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54760958 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54249198 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53959873 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52796786 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.52758917 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.52483059 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52440207 |
| 101 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51195320 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49471529 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49011615 |
| 104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49011488 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48891996 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47809915 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.46532194 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46360866 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46245041 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46193105 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44682816 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43540926 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42927380 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42708607 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42678685 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42664135 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42405637 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42380306 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41866984 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41602660 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39746658 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38829200 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38550767 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38431988 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.37472173 |
| 126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37357390 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.35906994 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35433119 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33847323 |
| 130 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33475978 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33048223 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32840900 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32793214 |
| 134 | Phagosome_Homo sapiens_hsa04145 | 0.32407845 |
| 135 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32275405 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31596526 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31269845 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.31030551 |
| 139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30582983 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27629983 |

